James Tislow

James Tislow is an experienced healthcare professional specializing in medical affairs and research within the pharmaceutical industry. Currently serving as Head of Medical Affairs Research and Senior Director of Medical Sciences at Cytokinetics since November 2019, Tislow has previously held significant roles at Merck Research Labs as Research Scientific Director in Cardiometabolic and at Gilead Sciences as Director of Medical Sciences for Cardiopulmonary Therapeutics. Earlier career experiences include positions at Schering-Plough Corporation, Astellas Pharma US, and various clinical and academic roles, with extensive expertise in engaging with key opinion leaders, overseeing clinical trials, and providing educational support. Tislow holds a Doctor of Pharmacy degree from Mercer University and an Associate of Arts in Pre-Pharmacy Studies from Northwest Florida State College.